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O B J E C T I V E S We sought to identify clinical and/or plaque characteristics that affect atherosclerotic
disease progression and arterial remodeling in the carotid artery with subclinical stenosis.
B A C KG ROUND Increasing severity of stenosis has been associated with a higher risk of stroke.
Factors that drive subclinical lesions to become stenotic plaques remain ambiguous. Carotid magnetic
resonance imaging (MRI) has been validated with histology to accurately quantify in vivo arterial
morphology and plaque composition.
METHOD S A total of 67 asymptomatic participants with 16% to 49% carotid stenosis as demon-
strated by duplex ultrasonography were imaged at 1.5-T with a carotid MRI protocol at baseline and at
18-month follow-up. Clinical and/or intra-arterial metrics with a signiﬁcant association with change in
plaque burden during multivariate analysis were evaluated for effects on lumen, wall, and total vessel
volume.
R E S U L T S From multiple regression analysis, intraplaque hemorrhage (IPH) (p  0.001) and statin
therapy (p 0.015) were identiﬁed as key determinants of change in plaque burden. The group with IPH
compared with the group without IPH demonstrated luminal narrowing, with a mean  SD decrease in
lumen volume (24.9  21.1 mm3/year vs. 0.5  26.9 mm3/year; p  0.005), a larger increase in wall
volume (44.1  36.1 mm3/year vs. 0.8  34.5 mm3/year; p  0.001), and no difference in total vessel
volume (19.3  27.4 mm3/year vs. 0.4  42.4 mm3/year; p  0.15). The nonstatin group compared with
the statin group demonstrated outward remodeling, with an increase in wall volume (22.4  35.6
mm3/year3/year vs. 0.9 38.0 mm3/year; p 0.026) and total vessel volume (19.2 36.9 mm3/year vs.4.9
 40.4 mm3/year; p  0.019) and no difference in lumen volume (5.8  26.6 mm3/year vs. 3.2  29.5
mm3/year; p  0.72).
CONC L U S I O N S IPH may represent an indication of accelerated plaque growth and impending
luminal compromise in the subclinical carotid artery. Statin therapy may stabilize lesions by slowing or
halting lesion progression. This phase of plaque stenosis (16% to 49%) may be a critical stage for intrinsic
and extrinsic factors to affect the atherosclerotic disease process. (J Am Coll Cardiol Img 2009;2:
1381–9) © 2009 by the American College of Cardiology Foundation
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1382rom natural history studies and multiple large
clinical trials, increasing severity of stenosis has
been associated with a higher risk of stroke. In
1987, Glagov et al. (1) proposed that luminal
arrowing occurred after plaque burden exceeded the
bility of the artery to outwardly remodel. From
bservations of postmortem coronary arteries, they
dentified luminal narrowing to occur after the ath-
rosclerotic lesion occupied greater than 40% of the
nternal elastic lamina area (1).
See page 1390
Support for the hypothesis of Glagov et al. (1) has
een reported in studies of the in vivo carotid arteries.
n a prospective magnetic resonance imaging (MRI)
tudy, Saam et al. (2) found an association between
laque burden and remodeling patterns in individuals
ith advanced carotid disease (50% to 79% stenosis).
vidence from histological studies (3), however, sug-
ests that factors beyond lesion size (e.g., plaque
omposition) may have an integral role in progression
and remodeling. In a case-control study of
individuals with 50% to 79% carotid steno-
sis, Takaya et al. (4) found that lesions with
intraplaque hemorrhage (IPH) at baseline
had a greater increase in wall volume and
reduction in lumen volume compared with
arteries without IPH. Although both studies
(2,4) provide insight into plaque features
associated with patterns of remodeling in
more advanced carotid atherosclerosis, nei-
her considers arterial changes that occur in carotid
rteries at a subclinical stage of atherosclerosis devel-
pment (50% stenosis). In addition, the study by
aam et al. (2) does not investigate the role of plaque
omposition, whereas the study by Takaya et al. (4)
oes not evaluate the impact of clinical risk factors on
rogression. As such, factors that drive earlier stage
esions to become stenotic plaques remain ambiguous.
In this study, we sought to identify the natural
istory of subclinical carotid atherosclerotic disease
nd to identify both clinical and intraplaque factors
hat contribute to disease progression and arterial
emodeling. In accord, we designed a prospective,
bservational study to serially evaluate in vivo ca-
otid atherosclerotic disease in individuals with
50% stenosis.
E T H O D S
tudy sample. Neurologically asymptomatic indi-
ge
re
reiduals with at least 1 carotid artery with 16% to t9% stenosis by duplex ultrasonography using
trandness criteria (5) were serially recruited from
he diagnostic vascular ultrasound laboratory at the
niversity of Washington Medical Center and the
eterans Affairs Puget Sound Health Care System.
easons for referral to the ultrasound laboratory of
symptomatic patients included the presence of a
ervical bruit and patients scheduled for coronary
rtery bypass graft or lower extremity bypass. The
rtery with 16% to 49% stenosis was designated as
he index artery and was selected for serial imaging
y carotid MRI. If both the right and left carotid
rteries had 16% to 49% stenosis, the index artery
as randomly assigned. All participants provided
nswers to a standardized health questionnaire at
oth imaging sessions. At the baseline scan, all
articipants had their height, weight, and mean
ystolic blood pressure (SBP) in both arms re-
orded. The study procedures and consent forms
ere reviewed and approved by the institutional
eview board before study initiation. Subjects were
symptomatic with respect to their carotid disease
efore enrollment. Exclusion criteria were previous
arotid endarterectomy on the index carotid, previ-
us radiation therapy to the neck, age older than 80
ears, renal insufficiency, and contraindication for
RI. Medications were not criteria for exclusion,
nd all patients were managed medically by their
rimary care providers for the duration of the
bservation period. During the period of observa-
ion, study participants were not enrolled in any
dditional imaging studies and data from these
articipants were not previously reported.
RI protocol. From November 7, 2003, to November
3, 2006, 80 participants were enrolled and underwent
arotid MRI at baseline and at 18-month follow-up
n a 1.5-T scanner (Signa Horizon EchoSpeed, Gen-
ral Electric Healthcare, Milwaukee, Wisconsin) us-
ng bilateral, 4-element, phased-array surface coils
Pathway MRI, Seattle, Washington). A standard-
zed multicontrast protocol (6) for carotid MRI was
sed to obtain 2-dimensional T1-, proton density-,
nd T2-weighted black-blood images and
-dimensional time-of-flight bright-blood angiog-
aphy. In addition, a contrast-enhanced, black-
lood T1-weighted sequence (7) was acquired 5
inutes after intravenous infusion of 0.1 mmol/kg
adolinium–DTPA-BMA (Omniscan, GE Healthcare)
t a rate of 2 ml/s. The 12 axial images with an in-plane
esolution of 0.62  0.62 mm2 were acquired with
2-mm slice thickness, for a total longitudinal
overage of 24 mm, centered at the bifurcation ofB B R E V I A T I O N S
N D A C R O N YM S
PH intraplaque hemorrha
RNC lipid-rich necrotic co
RImagnetic resonance
maginghe index artery.
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1383mage review. Two reviewers, blinded to time point
nd clinical information, matched the multicontrast
xial images of the index artery between time points
ased on distance from the bifurcation of the
arotid artery. All matched axial locations for the
ndex artery were evaluated for image quality (4-
oint scale: 1  poor, 4  excellent) and inter-
reted by reaching a consensus. In instances of
isagreement, a third blinded reviewer mediated a
ecision. For images with image quality 2 at both
ime points, image analysis software (CASCADE,
eattle, Washington) was used to draw the lumen
nd outer wall boundaries (8). Lumen volume, wall
olume, total vessel volume (lumen volume  wall
olume), and percentage of wall volume (100% 
all volume/total vessel volume) were recorded (the
ercentage of wall volume is a measure of plaque
urden similar to that proposed by Nissen et al. [9]
uring imaging investigations of the coronary arter-
es). The presence or absence of calcification, a
ipid-rich necrotic core (LRNC), and IPH were
etermined using multicontrast imaging criteria
reviously validated with histology (10,11). Volume
easurements of the LRNC and calcification,
hen present, were also collected. IPH was treated
s a dichotomous variable (present vs. absent) due
o decreased reproducibility of volume measure-
ents compared with the other metrics (10,12).
ata analysis. Summary statistics for each metric are
resented as mean  SD annualized rates for all
rteries included in each analysis. Change in the
ercentage of wall volume was compared with zero
sing the 1-sample t test. Univariate least-squares
egression analysis using each of the clinical and
aseline arterial variables identified in Table 1 as an
ndependent variable in separate analyses was con-
ucted to identify statistically significant predictors
f the percentage of wall volume change. In the
emographics and regression analysis, the presence
f statin therapy or diabetes mellitus indicates
resence during the observation period. All partic-
pants on statin therapy were taking statins for a
inimum of 3 months before the baseline scan. No
ubject had statin therapy initiated or discontinued
uring the period of observation. Statin therapy and
iabetes mellitus were entered as dichotomous vari-
bles, and the baseline type and dose were not used.
multivariate regression model was created for the
nnual change in the percentage of wall volume by
sing predictors identified during univariate analy-
is with a statistical association having p  0.10.
his inclusive regression model offers a conservativestimate of the association of each of the variables 1ith the outcome. The regression coefficients are
eported as unstandardized B  SE and standard-
zed coefficient beta for univariate and multivariate
odels.
Each metric with a significant association with
he change in the percentage of wall volume during
ultivariate analysis was evaluated for effects on
rterial remodeling. Outward remodeling was de-
ned as an increase in wall volume and total vessel
olume without a change in lumen volume. Lumi-
al narrowing was defined as an increase in wall
olume, a decrease in lumen volume, and no change
n total vessel volume. For dichotomous variables,
hange in lumen volume, wall volume, and total
essel volume were compared with zero using the
Table 1. Baseline Clinical and Arterial Data (n  67)
Mean  SD or % Ran
Age, yrs 69.8 9.2
Male sex, % 76.1
Body mass index, kg/m2 27.6 4.0
SBP, mm Hg* 139.7 17.3
Smoking, %
Never smoked 29.9
Quit 49.3
Active 20.9
History of coronary artery disease, % 34.3
History of claudication, % 17.9
Diabetes mellitus, % 17.9
Insulin† 66.7
Metformin† 41.7
Glyburide† 8.3
Glipizide† 8.3
Statin therapy, mg, % 64.2
Simvastatin† 41.9
Atorvastatin† 34.9
Lovastatin† 18.6
Pravastatin† 4.7
Statin therapy duration, months
3 0
3–12 32.6
12 67.4
Lumen volume, mm3 704.3 226.5
Wall volume, mm3 699.3 217.5
Total vessel volume, mm3 1,403.7 374.9
Percentage of wall volume 49.9 8.4
Presence of LRNC, % 58.2
Presence of calciﬁcation, % 68.7
Presence of IPH, % 17.9
LRNC volume (n  39), mm3 80.0 92.3
Calciﬁcation volume (n  46), mm3 35.9 39.0
*Missing data for 1 subject. †Percentage of diabetes mellitus or statin users.
IPH  intraplaque hemorrhage; LRNC  lipid-rich necrotic core; SBP  systolge or Dose (Median)
48–89
19.5–37.7
100.5–191.5
5–80 (20)
10–80 (20)
10–40 (20)
10–40
236.7–1,299.5
358.7–1,453.6
831.5–2,483.4
33.8–76.7
1.9–407.7
1.2–162.5-sample t test for each subgroup. The independent
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1384test was used to compare changes between sub-
roups within each metric. For continuous vari-
bles, data were partitioned into tertiles and an
dentical analysis was performed using the first and
ast tertiles as subgroups. Differences between sub-
roups of each metric were also evaluated using a
ultivariate model that controlled for each of the
ther metrics.
Changes in LRNC volume and calcification vol-
me were compared with 0 using the 1-sample t
est. The Pearson correlation coefficient r was used
o identify associations between the change in the
ercentage of wall volume and the change in plaque
omposition. All statistical calculations were made
sing SPSS version 12.0 for Windows (SPSS Inc.,
hicago, Illinois). Statistical significance, based on
-sided tests, was defined as a value of p  0.05.
E S U L T S
f the 80 participants enrolled, 67 (84%) had
atched baseline and 18-month carotid MRI scans
f sufficient image quality for identification and
uantification of the vessel boundaries and plaque
omposition. All subjects remained asymptomatic
uring the period of observation. The mean interval
etween scans was 17.8 0.1 months and the mean
overage was 19.8  0.3 mm. The demographics
nd baseline arterial characteristics for the assess-
ble study sample are presented in Table 1.
hange in plaque burden (percentage of wall volume).
or the study sample as a whole, there was a trend
oward an overall increase in the percentage of wall
olume (0.4  1.7% per year; p  0.070). Clinical and
rterial metrics associated with annual change in the
ercentage of wall volume determined from univariate
egression analysis are detailed in Table 2. Notably, the
aseline lumen volume (B  0.02  0.05 per 50-mm3
ncrease; p  0.66) and the baseline percentage of wall
olume (B  0.11  0.25 per 10% increase; p  0.65)
ere not listed in Table 2 due to a statistically non-
Table 2. Predictors of Annual Change in Percentage of Wall Vol
Univa
B  SE
Smoking status (per categorical increase from
nonsmoking)
0.62 0.28
Presence of statin therapy 0.69 0.42
SBP (per 10-mm increase in Hg) 0.24 0.12
Presence of IPH 2.16 0.47
LRNC volume (per 10-mm3 increase) 0.08 0.02Abbreviations as in Table 1.ignificant association with change in the percent-
ge of wall volume. Among the metrics identified
uring univariate analysis, multivariate analysis
dentified IPH (B  2.24  0.62% per year with
PH present; p  0.001), statin therapy (B 
0.99  0.36% per year with statin therapy
resent; p  0.008), and SBP (B  0.22  0.10%
er year per 10-mm Hg increase; p  0.031) as
redictors of change in the percentage of wall
olume (Table 2).
PH. There were 12 (17.9%) participants with IPH
t baseline. No subject developed IPH during the
eriod of observation. Lesions with IPH present
ompared with lesions without IPH demonstrated a
ignificant reduction in lumen volume (24.9 
1.1 mm3/year vs. 0.5  26.9 mm3/year, respec-
ively; p  0.005) (Fig. 1) and an increase in wall
olume (44.1  36.1 mm3/year vs. 0.8  34.5
m3/year, respectively; p  0.001) without a sig-
ificant difference in the total vessel volume (19.3
7.4 mm3/year vs. 0.4  42.4 mm3/year, respec-
ively; p  0.015). The magnitude and statistical
ignificance of these differences (or similarities)
ere comparable to the results from the multiple
egression analysis after controlling for statin ther-
py and SBP (Table 3).
tatin therapy. Subjects not on statin therapy com-
ared with those on statin therapy had a statistically
ignificant progression of wall volume (22.4  35.6
m3/year vs. 0.9  38.0 mm3 mm3/year, respec-
ively; p  0.026) and total vessel volume (19.2 
6.9 mm3/year vs. 4.9  40.4 mm3/year, respec-
ively; p  0.019) without a significant difference in
hange in lumen volume (3.2  29.5 mm3/year
s. 5.8  26.6 mm3/year, respectively; p  0.72).
he magnitude and statistical significance of the
ifferences increased after controlling for IPH and
BP (Table 3). The similarity in lumen volume
hange between these 2 subgroups was strength-
ned during multivariate analysis (Table 3). Neither
(%/year)
e Analysis Multivariate Analysis
Beta p Value B  SE Beta p Value
0.26 0.030 0.23 0.20 0.12 0.25
0.20 0.10 0.99 0.36 0.29 0.008
0.24 0.051 0.22 0.10 0.22 0.031
0.50 0.001 2.24 0.62 0.52 0.001
0.37 0.002 0.00 0.03 0.01 0.92ume
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1385onstatin nor statin users demonstrated a signifi-
ant change in lumen volume compared with base-
ine (Table 3). Of note, there were no significant
ifferences between the group on statin therapy for
12 months before enrollment (n  29) compared
ith the group on statin therapy for 3 to 12 months
efore enrollment (n  14) for change in lumen
olume (4.8  25.3 mm3/year vs. 7.7  30.0
m3/year, respectively; p 0.74), wall volume (2.7
2.5 mm3/year vs. 3.0  48.7 mm3/year, respec-
ively; p  0.65), and total vessel volume (2.1 
9.3 mm3/year vs.10.7 58.2 mm3/year, respec-
ively; p  0.61).
BP. The tertile with the highest SBP (147 mm
g) compared with the tertile with the lowest SBP
131 mm Hg) demonstrated a trend toward an
ncrease in wall volume (18.4  31.1 mm3/year vs.
1.0  45.8 mm3/year, respectively; p  0.010).
here was not a significant difference between the 2
Figure 1. In Vivo Evidence of the Effects of IPH
Images are serial axial sections through a lesion in the left internal
sequences. (A) Baseline scan; (B) corresponding matched axial imag
both time points. Notice the reduction in lumen area most pronoun
thickness indicative of luminal narrowing. Also present is calciﬁcatio
points. *Lumen of the internal carotid. IPH  intraplaque hemorrhaubgroups for change in lumen and total vessel aolume (Table 3). After controlling for IPH and
tatin therapy, the difference for change in wall
olume lessened, but was statistically significant
Table 3). Difference for change in lumen volume
nd total vessel volume remained statistically non-
ignificant (Table 3).
hange in plaque composition. There were 39
58.2%) and 46 (68.7%) participants with an
RNC and calcification present at baseline, respec-
ively. No participant without an LRNC (calcifica-
ion) at baseline developed an LRNC (calcification)
uring the observation period. There was a signif-
cant increase in LRNC volume (8.0  20.1 mm3/
ear; p  0.018). There was a strong association
etween change in the percentage of wall volume
nd change in LRNC volume (r 0.75, p 0.001)
Figs. 2 and 3). There was not a statistically
ignificant change from baseline (1.8  7.2 mm3/
ear; p  0.097) in calcification. There was a slight
tid artery from T1-weighted (T1W) and time-of-ﬂight (TOF)
t 18-month follow-up. The lesion contains IPH (arrowheads) at
in the ﬁrst 2 columns associated with an increase in the wall
rrows) that can be used to conﬁrm registration between time
JV  jugular vein.caro
es a
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1386all volume and change in the volume of calcifica-
ion (r  0.36, p  0.013) (Fig. 2).
I S C U S S I O N
uring this 18-month observational, prospective
nvestigation of 16% to 49% carotid stenosis, both
linical and intra-arterial factors were associated
ith dynamic carotid atherosclerotic disease. IPH,
tatin therapy, and SBP were identified as the
trongest predictors of change in plaque burden.
lthough increased SBP was associated with a
eneral increase in plaque burden, IPH and statin
herapy had more definite effects. IPH was associ-
ted with accelerated plaque growth and luminal
arrowing. In contrast, statin therapy slowed plaque
rogression. Moreover, in the absence of statin
herapy, expansion of plaque was associated with
utward arterial remodeling. Our findings from this
atural history study indicate that specific clinical
isk factors and IPH may drive plaque evolution and
rterial remodeling in subclinical carotid atheroscle-
otic disease.
Arterial remodeling was originally described in
he context of plaque burden. Glagov et al. (1)
escribed outward remodeling, an increase in the
otal vessel area, as an adaptive phenomenon that
reserves blood flow in response to atherosclerotic
isease. Luminal narrowing did not occur until the
Table 3. Absolute Change (mm3/year) in Arterial Morphology
Present*
(Mean  SD)
Ab
(Mean
IPH
No. of subjects 12
Lumen volume 24.9 21.1 (p 0.002) –0.5 26
Wall volume 44.1 36.1 (p 0.001) 0.8 34
Total vessel volume 19.3 27.4 (p 0.033) 0.4 42
Statin therapy
No. of subjects 43
Lumen volume 5.8 26.6 (p 0.16) 3.2 29
Wall volume 0.9 38.0 (p 0.88) 22.4 35
Total vessel volume 4.9 40.4 (p 0.43) 19.2 36
SBP
No. of subjects 23
Lumen volume 8.5 36.1 (p 0.27) 1.4 21
Wall volume 18.4 31.1 (p 0.009) 1.0 45
Total vessel volume 9.9 40.8 (p 0.25) 0.4 45
*One-sample t test of change (present or absent; for SBP, present  third tert
between groups with feature present or absent. ‡p value from multiple regress
therapy¶).
Abbreviations as in Table 1.therosclerotic lesion occupied 40% of the inter- ral elastic lamina area. In lesions with 50% to 79%
tenosis, Saam et al. (2) found changes (i.e., luminal
arrowing) in the carotid artery consistent with the
ypothesis of Glagov et al. (1). In the absence of
tatin therapy, we observed outward arterial remod-
ling in lesions in this study of patients with 16% to
9% stenosis, which further supports the hypothesis
f Glagov et al. (1). However, we also observed
uminal narrowing in our cohort. Our findings
ndicate that the accelerated expansion of plaque
urden associated with the presence of IPH may
nduce luminal narrowing. The alterations to lumi-
al morphology may have occurred because the
ocal environment evolved too rapidly to allow
ompensatory outward remodeling. Alternatively,
he hemorrhagic event may signify a fundamental
hange in the biology of the lesion. For example, a
hange in the composition of a lesion might pro-
uce a change in vascular remodeling, as was
escribed previously in balloon-injured rabbits (13).
IPH was previously associated with lesion insta-
ility in the carotid artery. In individuals with a
ecent history of cerebral ischemia, Murphy et al.
14) found IPH present in 67% of lesions with
70% stenosis. Altaf et al. (15) reported that the
resence of IPH in symptomatic patients with 30%
o 69% carotid stenosis was associated with a hazard
atio of 9.8 for the development of recurrent neu-
*
SD) p Value†
Regression
Coefﬁcients
p Value‡B  SE Beta
 0.90) 0.005 24.4 8.6 0.34 0.006§
 0.86) 0.001 48.8 10.1 0.49 0.001§
 0.95) 0.15 24.4 12.5 0.23 0.055§
 0.60) 0.72 1.2 6.9 0.02 0.86
 0.005) 0.026 28.6 8.1 0.36 0.001
 0.018) 0.019 27.4 10.0 –0.33 0.008
 0.75) 0.28 1.9 1.9 0.12 0.31¶
 0.92) 0.10 5.9 2.2 0.27 0.010¶
 0.97) 0.46 4.0 2.7 0.17 0.16¶
147 mm Hg] and absent  ﬁrst tertile [131 mm Hg]). †Independent t test
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138750% stenosis, Takaya et al. (16) reported that
PH was associated with a hazard ratio of 5.2 for a
uture ipsilateral ischemic event. IPH has also been
eported to accelerate plaque burden progression
nd increase the size of the LRNC in asymptom-
tic subjects with 50% to 79% stenosis (4). Our
ndings expand the integral role of IPH in the
atural history of carotid atherosclerosis to le-
ions with 16% to 49% stenosis. Previous studies
ombined with the data presented here strongly
uggest that IPH may act to destabilize lesion
ntegrity at any stage of plaque burden and
tenotic severity.
Multiple long-term, randomized studies have
emonstrated that statin therapy decreases the oc-
urrence of clinical events. We found evidence that
tatin therapy alters the natural history of in vivo
arotid atherosclerotic disease. Not all participants,
owever, responded similarly to statin therapy;
here were clear instances of regression (Figs. 2
nd 3) and progression (Fig. 2). Interestingly,
ndividuals on statin therapy and in the lowest
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Scatterplots of change in the percentage of wall volume versus cha
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the plots are identical with data points relabeled according to the p
therapy (B, E) and tertiles of systolic blood pressure (C, F). Of note,
diminished by IPH and may be enhanced in subjects in the lowestertile of SBP (131 mm Hg) demonstrated segression in both LRNC volume and plaque
urden. Furthermore, the effects of statin therapy
eemed to be offset by IPH and/or elevated SBP,
n established risk factor for cardiovascular dis-
ase. Although there were insufficient data to
tatistically evaluate the full extent of these rela-
ionships, these findings form the basis for large,
ong-term prospective studies that evaluate these
ypotheses.
tudy limitations. There are 2 limitations related to
ur analysis of statin therapy that warrant discus-
ion. First, statin therapy and dose were not ran-
omized and/or uniform across the study sample.
owever, our findings are consistent with those of
revious work that did not find a significant differ-
nce between high- and low-dose rosuvastatin in
arotid disease over a similar period of observation
17). Second, cholesterol levels (cross-sectional or
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herapy before study enrollment, which suggests
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1388revious double-blind, randomized, prospective
tudy did not find an association between change in
holesterol levels and change in plaque composition
Figure 3. In Vivo Evidence of Plaque Regression in a Statin Use
(A) Baseline scan; (B) 18-month follow-up scan. Multicontrast image
[T2W], and time-of-ﬂight [TOF]) from serial axial sections through th
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mon carotid. JV  jugular vein.17). Nevertheless, monitoring cholesterol levels puring future investigations may provide insight
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1-weighted [T1W], contrast-enhanced [CE]-T1W, T2-weighted
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e conclude that lesions with 16% to 49% stenosis
epresent a dynamic period of disease evolution. In
his demographic group, IPH may be an indication
f accelerated plaque growth and impending lumi-
al compromise in the carotid artery. Statin therapy
ay stabilize carotid lesions by slowing lesion
rogression, particularly in individuals with well-2002;48:899–905. ing. Circ Res 1998;8herapy substantially alter the natural history and
rterial remodeling of the carotid artery. The sub-
linical phase of plaque stenosis may be a critical
tage for both intrinsic and extrinsic factors to affect
he atherosclerotic disease process.
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